A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

NCT00000833 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ribavirin
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)